4.2 Abstract in Atti di convegno

4.2 Abstract in Atti di convegno: [2965] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 621 a 640 di 2.965

POTENTIALS OF 68GA-PROSTATE SPECIFIC MEMBRANE ANTIGEN PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER

2019-01-01 Lopci, E; Saita, A; Lughezzani, G; Castello, A; Colombo, P; Buffi, N; Hurle, R; Marzo, K; Leonardi, L; Benetti, A; Casale, P; Fasulo, V; Paciotti, M; Maffei, D; Domanico, L; Bevilacqua, G; Chiti, A; Balzarini, L; Guazzoni, G; Lazzeri, M

EANM/EARL FDG-PET/CT accreditation - summary results from the first 150 accredited imaging sites

2017-01-01 Kaalep, A; Sera, T; Oyen, W; Krause, Bj; Chiti, A; Liu, Y; Boellaard, R

F-18-FDG-PET (PET) and contrast-enhanced CT-scan (CT) in the evaluation of liver metastases from colorectal cancer after chemotherapy

2005-01-01 Carnaghi, Cv; Chiti, A; Marzo, K; Rodari, M; Rimassa, L; Tronconi, Mc; Santoro, A

Timing of response evaluation with 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) in malignant pleural mesothelioma (MPM): "Early'' versus "late'' assessment

2006-01-01 Ceresoli, Gl; Zucali, Pa; Rodari, M; De Vincenzo, F; Salamina, S; Campagnoli, E; Garassino, I; Lutman, Rf; Chiti, A; Santoro, A

Usefulness of FDG-PET imaging in HIV infected individuals for visualization and quantification of lymphatic tissue activation

2006-01-01 Orunesu, E; Gori, A; Clerici, M; Pacei, M; Marzo, K; Bechi, G; Cesari, M; Castelletti, E; Lucignani, G; Chiti, A

FDG PET predicts response in mesothelioma patients treated with pemetrexed based chemotherapy

2006-01-01 Chiti, A; Ceresoli, Gl; Rodari, M; Morenghi, E; Lutman, Rf; Tadayyon, S; Ciocia, G; Santoro, A

Clinical implications of immunohistochemical assessment of somatostatin receptors subtype 2 and 5 in the diagnostic and therapeutic management of gastro-entero-pancreatic neuroendocrine tumours

2007-01-01 Sclafani, F; Carnaghi, C; Di Tommaso, L; Chiti, A; Franchi, G; Rimassa, L; Tronconi, Mc; Roncalli, M; Santoro, A

MRI and FDG-PET image fusion to asses pancreatic lesions

2006-01-01 Rodari, M; Tridici, M; Tadayyon, S; Ciocia, G; Bonifacio, C; Poretti, D; Balzarini, L; Chiti, A

Absorbed dose from daily routine practice in an 18F-FDG producing radiopharmacy

2006-01-01 Marzo, K; Tosi, G; Chiti, A

18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy

2006-01-01 Rimassa, L.; Chiti, A.; Carnaghi, C.; Doci, R.; Torzilli, G; Zuradelli, M.; Tondulli, L.; Pressiani, T.; Lutman, F. R.; Tronconi, M. C.; Santoro, A.

Neurodegeneration in multiple sclerosis and neuromyelitis optica: an optical coherence tomography study

2018-01-01 Pisa, M; Vabanesi, M; Radaelli, M; Guerrieri, S; Ratti, F; Moiola, L; Martinelli, V; Comi, G; Leocani, L

DEFINING GENOTYPE-PHENOTYPE CORRELATIONS IN THE CMT NEUROPATHIES

2009-01-01 Benedetti, S; Coviello, S; Colombo, A; Piantoni, L; Spiga, I; Cerri, F; Scarlato, M; Fazio, R; Quattrini, A; Previtali, Sc; Bolino, A

CLINICAL AND MOLECULAR CHARACTERIZATION OF A COHORT OF PATIENTS WITH DISTAL MOTOR NEUROPATHY

2013-01-01 Riva, N; Scarlato, M; Scarlino, S; Del Bo, R; Comi, Gp; Corbo, M; Penco, S; Ferrari, M; Foglio, A; Grimaldi, Lm; Comi, G; Nobile-Orazio, E; Marrosu, Mg; Del Carro, U; Gerevini, S; Fazio, R; Quattrini, A; Bolino, A; Previtali, Sc

Normal sciatic nerve morphology and motor nerve conduction velocity in myotubularin deficient mice

2004-01-01 Buj-Bello, A; Meziane, H; Quattrini, A; Pellissier, Jf; Messaddeq, N; Bolino, A; Ouagazzal, Am; Mandel, Jl

DHPLC analysis of unrelated CMT patients in the Myotubularin related 2 gene, MTMR2, responsible for Charcot-Marie-Tooth disease type 4B

2000-01-01 Bolino, A; Lonie, L; Zimmer, M; Boerkoel, Cf; Monaco, Ap; Lupski, Jr

CYTOSKELETON AND PERIPHERAL NERVE MYELINATION: A NOVEL ROLE FOR VIMENTIN

2011-01-01 Lopez, Id; Triolo, D; Dina, G; Taveggia, C; Porrello, E; Rivellini, C; Cerri, F; Del Carro, U; Bolino, A; Quattrini, A; Previtali, Sc

A NEW FORM OF X-LINKED HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA (HPDR-II) MAPS IN THE XP11 REGION

1993-01-01 Devoto, M; Bolino, A; Enia, G; Zoccali, C; Romeo, G

CLONING AND COMPARATIVE MAPPING OF A CHROMOSOME-20-SPECIFIC ALPHOID DNA-SEQUENCE

1991-01-01 Baldini, A; Archidiacono, N; Carbone, R; Bolino, A; Shridhar, V; Miller, O; Miller, Da; Ward, Dc; Rocchi, M

MODULATION OF NEUREGULIN 1 TYPE III PATHWAY TO TREAT HEREDITARY DEMYELINATING NEUROPATHIES

2013-01-01 Piguet, F; Scarlino, S; Taveggia, C; Rivellini, C; Previtali, Sc; Bolino, A

DLG1 IS A NEGATIVE REGULATOR OF SCHWANN CELL MYELINATION

2011-01-01 Belin, S; Noseda, R; Vaccari, I; Dina, G; Feltri, Ml; Huganir, Rl; Quattrini, A; Bolino, A

Titolo	Data di pubblicazione	Autore(i)
POTENTIALS OF 68GA-PROSTATE SPECIFIC MEMBRANE ANTIGEN PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER	1-gen-2019	Lopci, E; Saita, A; Lughezzani, G; Castello, A; Colombo, P; Buffi, N; Hurle, R; Marzo, K; Leonardi, L; Benetti, A; Casale, P; Fasulo, V; Paciotti, M; Maffei, D; Domanico, L; Bevilacqua, G; Chiti, A; Balzarini, L; Guazzoni, G; Lazzeri, M
EANM/EARL FDG-PET/CT accreditation - summary results from the first 150 accredited imaging sites	1-gen-2017	Kaalep, A; Sera, T; Oyen, W; Krause, Bj; Chiti, A; Liu, Y; Boellaard, R
F-18-FDG-PET (PET) and contrast-enhanced CT-scan (CT) in the evaluation of liver metastases from colorectal cancer after chemotherapy	1-gen-2005	Carnaghi, Cv; Chiti, A; Marzo, K; Rodari, M; Rimassa, L; Tronconi, Mc; Santoro, A
Timing of response evaluation with 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) in malignant pleural mesothelioma (MPM): "Early'' versus "late'' assessment	1-gen-2006	Ceresoli, Gl; Zucali, Pa; Rodari, M; De Vincenzo, F; Salamina, S; Campagnoli, E; Garassino, I; Lutman, Rf; Chiti, A; Santoro, A
Usefulness of FDG-PET imaging in HIV infected individuals for visualization and quantification of lymphatic tissue activation	1-gen-2006	Orunesu, E; Gori, A; Clerici, M; Pacei, M; Marzo, K; Bechi, G; Cesari, M; Castelletti, E; Lucignani, G; Chiti, A
FDG PET predicts response in mesothelioma patients treated with pemetrexed based chemotherapy	1-gen-2006	Chiti, A; Ceresoli, Gl; Rodari, M; Morenghi, E; Lutman, Rf; Tadayyon, S; Ciocia, G; Santoro, A
Clinical implications of immunohistochemical assessment of somatostatin receptors subtype 2 and 5 in the diagnostic and therapeutic management of gastro-entero-pancreatic neuroendocrine tumours	1-gen-2007	Sclafani, F; Carnaghi, C; Di Tommaso, L; Chiti, A; Franchi, G; Rimassa, L; Tronconi, Mc; Roncalli, M; Santoro, A
MRI and FDG-PET image fusion to asses pancreatic lesions	1-gen-2006	Rodari, M; Tridici, M; Tadayyon, S; Ciocia, G; Bonifacio, C; Poretti, D; Balzarini, L; Chiti, A
Absorbed dose from daily routine practice in an 18F-FDG producing radiopharmacy	1-gen-2006	Marzo, K; Tosi, G; Chiti, A
18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy	1-gen-2006	Rimassa, L.; Chiti, A.; Carnaghi, C.; Doci, R.; Torzilli, G; Zuradelli, M.; Tondulli, L.; Pressiani, T.; Lutman, F. R.; Tronconi, M. C.; Santoro, A.
Neurodegeneration in multiple sclerosis and neuromyelitis optica: an optical coherence tomography study	1-gen-2018	Pisa, M; Vabanesi, M; Radaelli, M; Guerrieri, S; Ratti, F; Moiola, L; Martinelli, V; Comi, G; Leocani, L
DEFINING GENOTYPE-PHENOTYPE CORRELATIONS IN THE CMT NEUROPATHIES	1-gen-2009	Benedetti, S; Coviello, S; Colombo, A; Piantoni, L; Spiga, I; Cerri, F; Scarlato, M; Fazio, R; Quattrini, A; Previtali, Sc; Bolino, A
CLINICAL AND MOLECULAR CHARACTERIZATION OF A COHORT OF PATIENTS WITH DISTAL MOTOR NEUROPATHY	1-gen-2013	Riva, N; Scarlato, M; Scarlino, S; Del Bo, R; Comi, Gp; Corbo, M; Penco, S; Ferrari, M; Foglio, A; Grimaldi, Lm; Comi, G; Nobile-Orazio, E; Marrosu, Mg; Del Carro, U; Gerevini, S; Fazio, R; Quattrini, A; Bolino, A; Previtali, Sc
Normal sciatic nerve morphology and motor nerve conduction velocity in myotubularin deficient mice	1-gen-2004	Buj-Bello, A; Meziane, H; Quattrini, A; Pellissier, Jf; Messaddeq, N; Bolino, A; Ouagazzal, Am; Mandel, Jl
DHPLC analysis of unrelated CMT patients in the Myotubularin related 2 gene, MTMR2, responsible for Charcot-Marie-Tooth disease type 4B	1-gen-2000	Bolino, A; Lonie, L; Zimmer, M; Boerkoel, Cf; Monaco, Ap; Lupski, Jr
CYTOSKELETON AND PERIPHERAL NERVE MYELINATION: A NOVEL ROLE FOR VIMENTIN	1-gen-2011	Lopez, Id; Triolo, D; Dina, G; Taveggia, C; Porrello, E; Rivellini, C; Cerri, F; Del Carro, U; Bolino, A; Quattrini, A; Previtali, Sc
A NEW FORM OF X-LINKED HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA (HPDR-II) MAPS IN THE XP11 REGION	1-gen-1993	Devoto, M; Bolino, A; Enia, G; Zoccali, C; Romeo, G
CLONING AND COMPARATIVE MAPPING OF A CHROMOSOME-20-SPECIFIC ALPHOID DNA-SEQUENCE	1-gen-1991	Baldini, A; Archidiacono, N; Carbone, R; Bolino, A; Shridhar, V; Miller, O; Miller, Da; Ward, Dc; Rocchi, M
MODULATION OF NEUREGULIN 1 TYPE III PATHWAY TO TREAT HEREDITARY DEMYELINATING NEUROPATHIES	1-gen-2013	Piguet, F; Scarlino, S; Taveggia, C; Rivellini, C; Previtali, Sc; Bolino, A
DLG1 IS A NEGATIVE REGULATOR OF SCHWANN CELL MYELINATION	1-gen-2011	Belin, S; Noseda, R; Vaccari, I; Dina, G; Feltri, Ml; Huganir, Rl; Quattrini, A; Bolino, A

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 621 a 640 di 2.965

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext2916
reserved33
open16